Welcome to our dedicated page for Cybin SEC filings (Ticker: CYBN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CYBN SEC filings page on Stock Titan aggregates Cybin Inc.’s regulatory disclosures as a foreign issuer, giving investors structured access to the company’s official documents. Cybin files with the U.S. Securities and Exchange Commission primarily on Form 40-F and Form 6-K, and also uses Form 25 for listing changes. These filings are central to understanding the company’s clinical-stage neuropsychiatry business, its capital structure, and its transition between stock exchanges.
Form 6-K submissions for Cybin typically include interim consolidated financial statements, management’s discussion and analysis, certifications of interim filings, and news releases. Many 6-Ks also incorporate material change reports, equity distribution agreements, and prospectus-related documents by reference into Cybin’s registration statements on Form F-10. For a company developing drug candidates such as CYB003 for major depressive disorder and CYB004 for generalized anxiety disorder, these filings provide context on how clinical programs are funded and governed.
The filings page also features Cybin’s Form 25, which notifies the SEC of the voluntary removal of its common shares from listing and registration on the NYSE American. This document confirms that the company has complied with the exchange’s rules and the requirements for voluntary withdrawal, and it aligns with Cybin’s news release describing its plan to transfer its U.S. listing to the Nasdaq Global Market and to change its trading symbol from CYBN to HELP.
On Stock Titan, each new Cybin filing from EDGAR is captured and presented with AI-powered summaries that explain the purpose and key points of documents such as 6-Ks, F-10 registration statements, and the Form 25 delisting notice. This helps readers quickly understand how Cybin reports its financial results, documents material changes, and manages its listing status, while still allowing direct access to the underlying SEC filings for detailed review.
Cybin Inc. filed a Form D for a Rule 506(b) exempt securities offering to permit exercise of stock options that could generate up to $288,280 USD (CAD conversion provided). The securities are stock options exercisable at CAD$10.00 per share that vest in eight quarterly tranches beginning September 30, 2025. The filing reports 0 amount sold to date, 288,280 USD remaining to be sold, and 10 total investors (also listed as 10 non-accredited investors). The offering is intended to last more than one year, minimum investment accepted is $0 USD, and no sales commissions or finders' fees are reported.
CYBIN INC. filed a Form D notice reporting a Regulation D exempt offering of options. The filing states a total potential offering amount of $637,404 USD (maximum proceeds from option exercises) and that $0 has been sold to date. The securities are stock options exercisable at CAD$11.00 per share that vest in eight quarterly tranches beginning September 30, 2025. The issuer selected Rule 506(b) as the exemption and indicated the offering may last more than one year. The Form D lists two investors in the offering, both non-accredited, and discloses no sales commissions or finders' fees and $0 proposed for payments to named executives or directors.
Point72 affiliates reported holding 1,606,317 common shares of Cybin Inc., representing 7.0% of the outstanding class as of June 30, 2025. The filing lists Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen as reporting persons; each reports 0 sole voting or dispositive power and 1,606,317 shared voting and dispositive power. The statement clarifies that the shares are held by Point72 Associates, an investment fund managed by Point72 Asset Management, and that the filing is not an admission of beneficial ownership for Section 13 purposes. The signee is Jason M. Colombo, as authorized person, dated August 14, 2025.
Cybin Inc. filed a Form 6-K as a foreign private issuer for August 2025. The filing states that two exhibits are incorporated by reference into the company’s existing Form F-10 shelf registration statement. These exhibits are a form of amended and restated convertible note and an omnibus amendment dated August 12, 2025. The document is signed by Chief Executive Officer Doug Drysdale.